The Patent Finder

Terms ending in 2038

Purdue Pharma L.P.

Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,297,199Morphinan Derivatives and Use Thereof
In force
 · Medium confidence
Purdue Pharma L.P.In forceMedium confidence
US 11,413,276Compounds for Treating TNBC
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 11,786,509Compounds for Treating TNBC
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 11,918,558Tinostamustine for Use in the Treatment of T-Cell Prolymphocytic Leukaemia
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 12,303,492Compounds for Treating TNBC
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 12,370,178Tinostamustine for Use in the Treatment of T-Cell Prolymphocytic Leukaemia
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 12,201,629Method of Treatment and Dosage Forms Thereof
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 11,318,117Tinostamustine for Use in the Treatment of T-Cell Prolymphocytic Leukaemia
In force
 · High confidence
Mundipharma Edo GmbHIn forceHigh confidence
US 11,896,583Tinostamustine for Use in Treating Ovarian Cancer
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 11,911,510Pharmaceutical Dosage Forms
In force
 · High confidence
Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.In forceHigh confidence
3 more term ends in 2038 · Pro
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Upgrade to Pro
5 of these are in force and held by Purdue Pharma L.P..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited